Nifty
:
24968.40
Sensex
:
81757.73
-143.05 (-0.57%)
-501.51 (-0.61%)
Nifty
Sensex
:
:
24968.40
81757.73
-143.05 (-0.57%)
-501.51 (-0.61%)

Wockhardt Ltd.

Pharmaceuticals & Drugs - Global

Rating :
61/99

BSE: 532300 | NSE: WOCKPHARMA

NSE BSE
1773.90
18-Jul-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1822
  •  1826.5
  •  1768.3
  •  1820.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  466112
  •  833818272.6
  •  1868.8
  •  750

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 28,798.94
  • N/A
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 30,466.94
  • N/A
  • 6.63

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.09%
  • 3.15%
  • 26.04%
  • FII
  • DII
  • Others
  • 7.29%
  • 8.50%
  • 5.93%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -3.83
  • 2.15
  • 4.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.27
  • -
  • 31.22

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -30.93
  • -56.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.07
  • 2.16
  • 2.67

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 67.12
  • 47.05
  • 50.70

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
-32.1
-3.02
17
44
P/E Ratio
-55.26
-587.38
104.35
40.32
Revenue
2789
3012
5355
5799
EBITDA
39
1388
1328
Net Income
-463
-47
238
638
ROA
-6
P/B Ratio
15.15
ROE
-13.79
FCFF
-34
FCFF Yield
-0.14
Net Debt
1827
BVPS
117.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
743.00
700.00
6.14%
721.00
701.00
2.85%
809.00
753.00
7.44%
739.00
644.00
14.75%
Expenses
679.00
803.00
-15.44%
593.00
664.00
-10.69%
699.00
681.00
2.64%
648.00
628.00
3.18%
EBITDA
64.00
-103.00
-
128.00
37.00
245.95%
110.00
72.00
52.78%
91.00
16.00
468.75%
EBIDTM
8.61%
-14.71%
17.75%
5.28%
13.60%
9.56%
12.31%
2.48%
Other Income
15.00
54.00
-72.22%
8.00
8.00
0.00%
9.00
24.00
-62.50%
30.00
14.00
114.29%
Interest
48.00
73.00
-34.25%
60.00
77.00
-22.08%
73.00
76.00
-3.95%
73.00
79.00
-7.59%
Depreciation
53.00
58.00
-8.62%
55.00
55.00
0.00%
55.00
55.00
0.00%
54.00
55.00
-1.82%
PBT
-22.00
-180.00
-
21.00
-87.00
-
-9.00
-35.00
-
-6.00
-118.00
-
Tax
23.00
-3.00
-
1.00
-1.00
-
7.00
38.00
-81.58%
10.00
18.00
-44.44%
PAT
-45.00
-177.00
-
20.00
-86.00
-
-16.00
-73.00
-
-16.00
-136.00
-
PATM
-6.06%
-25.29%
2.77%
-12.27%
-1.98%
-9.69%
-2.17%
-21.12%
EPS
-1.54
-10.97
-
0.86
-5.76
-
-1.43
-5.35
-
-0.91
-9.31
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
-
3,012.00
2,798.00
2,651.00
3,230.00
2,708.00
3,325.15
4,158.38
3,936.90
4,014.61
4,453.22
Net Sales Growth
-
7.65%
5.55%
-17.93%
19.28%
-18.56%
-20.04%
5.63%
-1.94%
-9.85%
 
Cost Of Goods Sold
-
1,132.00
1,165.00
1,111.00
1,267.00
1,135.00
1,203.45
1,636.31
1,797.53
1,662.07
1,613.68
Gross Profit
-
1,880.00
1,633.00
1,540.00
1,963.00
1,573.00
2,121.70
2,522.07
2,139.37
2,352.54
2,839.54
GP Margin
-
62.42%
58.36%
58.09%
60.77%
58.09%
63.81%
60.65%
54.34%
58.60%
63.76%
Total Expenditure
-
2,619.00
2,759.00
2,550.00
2,932.00
2,771.00
3,082.03
4,050.63
3,935.07
3,988.39
3,958.98
Power & Fuel Cost
-
113.00
107.00
103.00
98.00
82.00
85.41
93.30
77.80
110.10
113.99
% Of Sales
-
3.75%
3.82%
3.89%
3.03%
3.03%
2.57%
2.24%
1.98%
2.74%
2.56%
Employee Cost
-
651.00
629.00
637.00
749.00
763.00
743.33
800.38
937.06
966.51
950.77
% Of Sales
-
21.61%
22.48%
24.03%
23.19%
28.18%
22.35%
19.25%
23.80%
24.07%
21.35%
Manufacturing Exp.
-
170.00
142.00
126.00
169.00
145.00
120.90
153.76
135.27
179.40
228.07
% Of Sales
-
5.64%
5.08%
4.75%
5.23%
5.35%
3.64%
3.70%
3.44%
4.47%
5.12%
General & Admin Exp.
-
196.00
190.00
192.00
224.00
251.00
186.55
380.13
476.66
504.43
405.85
% Of Sales
-
6.51%
6.79%
7.24%
6.93%
9.27%
5.61%
9.14%
12.11%
12.56%
9.11%
Selling & Distn. Exp.
-
137.00
125.00
134.00
180.00
132.00
141.18
176.22
208.89
205.30
241.11
% Of Sales
-
4.55%
4.47%
5.05%
5.57%
4.87%
4.25%
4.24%
5.31%
5.11%
5.41%
Miscellaneous Exp.
-
220.00
401.00
247.00
245.00
263.00
601.21
810.53
301.86
360.58
241.11
% Of Sales
-
7.30%
14.33%
9.32%
7.59%
9.71%
18.08%
19.49%
7.67%
8.98%
9.11%
EBITDA
-
393.00
39.00
101.00
298.00
-63.00
243.12
107.75
1.83
26.22
494.24
EBITDA Margin
-
13.05%
1.39%
3.81%
9.23%
-2.33%
7.31%
2.59%
0.05%
0.65%
11.10%
Other Income
-
62.00
83.00
122.00
20.00
132.00
60.08
21.02
120.23
100.83
66.10
Interest
-
254.00
305.00
302.00
299.00
249.00
275.74
265.14
255.49
225.27
128.96
Depreciation
-
217.00
223.00
251.00
247.00
246.00
224.14
163.95
149.53
148.93
141.91
PBT
-
-16.00
-406.00
-330.00
-228.00
-426.00
-196.68
-300.32
-282.96
-247.15
289.47
Tax
-
41.00
52.00
-3.00
-132.00
-271.00
-153.29
-83.66
25.70
-21.11
37.88
Tax Rate
-
-256.25%
-12.38%
0.48%
32.12%
47.71%
77.94%
27.86%
-4.01%
8.54%
13.09%
PAT
-
-47.00
-463.00
-559.00
-244.00
-299.00
-69.22
-194.53
-608.30
-195.72
250.08
PAT before Minority Interest
-
-57.00
-472.00
-621.00
-279.00
-297.00
-43.39
-216.66
-666.85
-226.04
251.59
Minority Interest
-
10.00
9.00
62.00
35.00
-2.00
-25.83
22.13
58.55
30.32
-1.51
PAT Margin
-
-1.56%
-16.55%
-21.09%
-7.55%
-11.04%
-2.08%
-4.68%
-15.45%
-4.88%
5.62%
PAT Growth
-
-
-
-
-
-
-
-
-
-
 
EPS
-
-2.89
-28.49
-34.40
-15.02
-18.40
-4.26
-11.97
-37.43
-12.04
15.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
4,352.00
3,359.00
3,354.00
3,849.00
3,376.00
2,671.67
2,674.80
2,852.15
3,336.71
3,775.12
Share Capital
81.00
77.00
72.00
72.00
55.00
55.37
55.34
55.32
55.27
55.25
Total Reserves
4,260.00
3,269.00
3,266.00
3,759.00
3,293.00
2,586.33
2,587.19
2,760.11
3,244.43
3,691.22
Non-Current Liabilities
887.00
617.00
-22.00
261.00
496.00
1,194.85
1,702.75
2,088.89
3,151.38
1,893.49
Secured Loans
274.00
0.00
222.00
260.00
500.00
1,237.44
1,653.25
2,167.84
2,887.11
1,647.34
Unsecured Loans
937.00
891.00
2.00
95.00
3.00
3.46
238.22
5.27
303.16
273.26
Long Term Provisions
29.00
28.00
26.00
32.00
84.00
45.60
53.48
64.89
94.23
70.74
Current Liabilities
2,043.00
2,791.00
3,435.00
3,207.00
3,121.00
3,497.18
2,863.66
2,691.71
1,978.81
1,841.85
Trade Payables
592.00
766.00
867.00
921.00
696.00
895.27
840.24
601.78
533.81
637.69
Other Current Liabilities
887.00
1,144.00
1,172.00
1,197.00
1,230.00
1,579.80
1,353.09
1,548.13
690.13
621.23
Short Term Borrowings
496.00
832.00
1,330.00
1,034.00
1,066.00
903.86
561.71
437.09
662.80
550.03
Short Term Provisions
68.00
49.00
66.00
55.00
129.00
118.25
108.62
104.71
92.07
32.90
Total Liabilities
7,586.00
7,070.00
7,075.00
7,670.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
Net Block
2,736.00
2,881.00
3,042.00
3,462.00
3,343.00
3,502.29
3,057.93
2,887.96
2,772.55
2,808.70
Gross Block
5,814.00
5,721.00
5,696.00
6,019.00
5,656.00
6,703.28
6,112.89
5,772.29
5,456.40
4,377.01
Accumulated Depreciation
3,078.00
2,840.00
2,654.00
2,557.00
2,313.00
3,200.99
3,054.96
2,884.33
2,683.85
1,568.31
Non Current Assets
5,017.00
4,886.00
4,867.00
5,081.00
4,951.00
5,319.66
4,756.39
4,598.88
4,313.57
4,023.94
Capital Work in Progress
2,033.00
1,722.00
1,539.00
1,342.00
1,379.00
1,584.53
1,445.48
1,432.57
1,243.95
1,036.05
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.45
0.45
0.45
0.45
0.45
Long Term Loans & Adv.
246.00
266.00
269.00
259.00
228.00
230.63
252.37
277.90
296.62
178.74
Other Non Current Assets
2.00
17.00
17.00
18.00
1.00
1.76
0.16
0.00
0.00
0.00
Current Assets
2,465.00
2,073.00
1,914.00
2,445.00
2,425.00
2,429.83
2,814.65
3,379.60
4,535.27
3,951.85
Current Investments
422.00
0.00
0.00
0.00
0.00
0.00
0.00
213.25
562.27
0.00
Inventories
725.00
640.00
658.00
769.00
799.00
689.83
819.36
855.71
1,107.95
1,102.16
Sundry Debtors
661.00
618.00
797.00
918.00
918.00
1,242.69
1,273.90
962.45
1,034.45
1,111.42
Cash & Bank
191.00
529.00
124.00
406.00
292.00
268.46
448.65
1,082.25
1,603.61
1,478.11
Other Current Assets
466.00
0.00
0.00
0.00
416.00
228.85
272.74
265.94
226.99
260.16
Short Term Loans & Adv.
466.00
286.00
335.00
352.00
272.00
172.21
252.56
257.63
197.75
260.16
Net Current Assets
422.00
-718.00
-1,521.00
-762.00
-696.00
-1,067.35
-49.01
687.89
2,556.46
2,110.00
Total Assets
7,482.00
6,959.00
6,781.00
7,526.00
7,376.00
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-22.00
219.00
153.00
413.00
-287.00
648.96
183.32
68.44
-269.47
71.61
PBT
-16.00
-420.00
-624.00
-411.00
916.00
-196.68
-300.32
-641.15
-247.15
357.01
Adjustment
455.00
677.00
635.00
554.00
-943.00
483.23
444.52
448.78
303.04
201.29
Changes in Working Capital
-492.00
-8.00
153.00
367.00
-143.00
379.58
80.29
278.33
-297.39
-402.76
Cash after chg. in Working capital
-53.00
249.00
164.00
510.00
-170.00
666.13
224.49
85.96
-241.50
155.54
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
31.00
-30.00
-11.00
-97.00
-117.00
-17.17
-41.17
-17.52
-27.97
-83.93
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-783.00
-137.00
-125.00
-201.00
1,470.00
-155.53
94.57
630.24
-686.64
-818.19
Net Fixed Assets
-411.00
-1.00
31.00
-416.00
-200.42
-499.84
-39.00
-45.55
-166.75
-368.17
Net Investments
-422.00
0.00
0.00
0.00
0.27
0.00
-0.05
0.00
0.00
0.00
Others
50.00
-136.00
-156.00
215.00
1,670.15
344.31
133.62
675.79
-519.89
-450.02
Cash from Financing Activity
409.00
334.00
-315.00
-71.00
-1,171.00
-679.58
-776.45
-769.47
1,254.49
254.26
Net Cash Inflow / Outflow
-396.00
416.00
-287.00
141.00
12.00
-186.15
-498.56
-70.79
298.38
-492.32
Opening Cash & Equivalents
505.00
90.00
370.00
232.00
219.00
397.34
897.24
963.64
662.98
1,158.69
Closing Cash & Equivalent
112.00
505.00
90.00
370.00
232.00
219.34
397.34
897.24
963.64
664.64

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
267.96
217.27
231.81
266.04
280.48
238.55
238.75
254.47
298.51
339.05
ROA
-0.78%
-6.67%
-8.42%
-3.71%
-3.93%
-0.57%
-2.79%
-7.93%
-2.69%
3.25%
ROE
-1.48%
-14.12%
-17.32%
-7.77%
-9.92%
-1.64%
-7.94%
-21.81%
-6.42%
7.07%
ROCE
4.07%
-2.15%
-5.88%
-1.96%
-5.50%
1.32%
-0.56%
-5.47%
-0.31%
6.87%
Fixed Asset Turnover
0.67
0.63
0.73
0.88
0.75
0.52
0.70
0.70
0.82
1.00
Receivable days
60.36
71.63
73.25
65.29
85.04
138.12
98.15
92.57
97.55
75.93
Inventory Days
64.42
65.71
60.95
55.76
58.60
82.83
73.51
91.03
100.47
87.00
Payable days
218.94
255.81
293.71
232.91
255.87
129.66
86.65
67.29
64.08
64.54
Cash Conversion Cycle
-94.15
-118.47
-159.51
-111.86
-112.23
91.29
85.01
116.31
133.94
98.39
Total Debt/Equity
0.43
0.63
0.57
0.49
0.70
1.22
1.28
1.33
1.26
0.71
Interest Cover
0.94
-0.38
-1.07
-0.37
-1.28
0.29
-0.13
-1.51
-0.10
3.24

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Wockhardt initiates strategic realignment of US operations to focus on innovative portfolio
    11th Jul 2025, 17:42 PM

    The company has taken decision to exit the US generic pharmaceutical segment, paving the way for deeper focus and investment in its advanced product portfolio

    Read More
  • Wockhardt eyeing to launch new antibiotic in second half of FY25-26
    6th Jun 2025, 16:00 PM

    The company is aiming $7 billion market opportunity in US and European market with this drug

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.